PLRXPliant Therapeutics, Inc.

$82M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$666,000

Operating Income

-$31M

Net Income

-$30M

EPS (Diluted)

$-1.83

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$31M

Stock-Based Comp.

$228,000

Balance Sheet

Total Assets

$67M

Total Liabilities

$67M

Stockholders' Equity

-$882,000

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$666,000	$0	—
Operating Income	-$31M	-$18M	-68.5%
Net Income	-$30M	-$21M	-46.8%

PLRX FY 2018 Earnings — Pliant Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena